Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 476
Immune Disorders Drugs 202
Drug Discovery 170
Cardiovascular Drugs 157
Infectious Diseases Drugs 135
Biopharmaceuticals 130
Clinical Trials 125
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 85
Hematological Drugs 84
Liver and Kidney Disorders Drugs 79
Lymphoma Drugs 62
Diabetes Drugs 55
Dermatological Drugs 55
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 42
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Drug Delivery 37
Pharmaceutical Intermediates 36
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 32
Infusions and Injectables 30
Liver Cancer Drugs 28
Analgesics 25
Drugs by Therapeutic Area 24
Bladder Cancer Drugs 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Schizophrenia Drugs 19
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Breast Cancer Drugs 14
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Alzheimer's Disease Drugs 8
Optical Disorders Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



272 reviews

2,452 Results (Page 73 of 123)
- Relevance
  Sort by

Therapeutic Antibody Market (2023 Edition): Analysis By Antibody Type (Monoclonal, Bispecific, Drug Conjugates, Others), Source (Fully human, Humanized, Others), By Application, By Region, By Country: Market Insights and Forecast (2019-2029)

 Report
February 2024
260 Pages
Global

From

€2241EUR$2,450USD£1,907GBP

Leukemia Cancer Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
102 Pages
Global

From

€3500EUR$4,099USD£3,084GBP

Cancer Therapies - Global Strategic Business Report

 Report
May 2025
590 Pages
Global

From

€5350EUR$5,850USD£4,554GBP

Venous Thromboembolism Therapeutic Market by Drug Class, Device, Application, End-use - Global Forecast 2025-2030

 Report
October 2024
183 Pages
Global

From

€3242EUR$3,545USD£2,760GBP

€3603EUR$3,939USD£3,067GBP

Thrombosis Drug Market by Drug Class, Disease Type, Distribution Channel - Global Forecast 2025-2030

 Report
October 2024
181 Pages
Global

From

€3242EUR$3,545USD£2,760GBP

€3603EUR$3,939USD£3,067GBP

NEED HELP FINDING THE RIGHT PRODUCT? Eman will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Protein Therapeutics Market 2024-2028

 Report
May 2024
191 Pages
Global

From

€2286EUR$2,500USD£1,946GBP

Hodgkin Lymphoma Treatment Market - Growth, Trends and Forecasts (2023 - 2028)

 Report
April 2023
110 Pages
Global

From

€4344EUR$4,750USD£3,698GBP

Auto-Injectors Market by Component (Activation Button, Needle, Pen Cap), Type (Disposable, Reusable), Mode of Administration, Distribution Channel, Therapeutic Use, End Use - Global Forecast 2025-2030

 Report
March 2025
196 Pages
Global

From

€3242EUR$3,545USD£2,760GBP

€3603EUR$3,939USD£3,067GBP

Malignant Lymphoma Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
July 2024
74 Pages
Global

From

€3500EUR$4,099USD£3,084GBP

Keloids Treatment Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4107EUR$4,490USD£3,496GBP

Hidradenitis Suppurativa Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4107EUR$4,490USD£3,496GBP

Idiopathic Pulmonary Fibrosis Treatment Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Type, Distribution Channel, and Geography

 Report
December 2023
150 Pages
Global

From

€4070EUR$4,450USD£3,464GBP

Cancer Biologics Market 2024-2028

 Report
February 2024
169 Pages
Global

From

€2286EUR$2,500USD£1,946GBP

Pigmentation Disorders Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4107EUR$4,490USD£3,496GBP

Pruritus Therapeutics Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4107EUR$4,490USD£3,496GBP

Global Pain Management Drugs Market, By Drug Class, By Indication, By Pain Type, By Drug Type, By Distribution Channel, Estimation & Forecast, 2017 - 2030

 Report
January 2022
278 Pages
Global

From

€3887EUR$4,250USD£3,309GBP

Pain Management Drugs Market Demand and Pipeline Insights (2022 Edition) - Analysis By Drug Type, Route of Administration, End-Use, Availability, Sales Channel, By Region, By Country: Market Insights & Forecast with Impact of COVID-19 (2023-2028)

 Drug Pipelines
September 2022
280 Pages
Global

From

€2195EUR$2,400USD£1,868GBP

Waldenstrom's Macroglobulinemia (WM) Treatment Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)

 Report
January 2023
110 Pages
Global

From

€4344EUR$4,750USD£3,698GBP

Myocardial Infarction (MI) Therapeutics Market 2024-2028

 Report
October 2024
149 Pages
Global

From

€2286EUR$2,500USD£1,946GBP

Idiopathic Pulmonary Fibrosis Treatment Market Report by Drug Class (MAPK Inhibitors, Tyrosine Inhibitors, Autotaxin Inhibitors), End User (Hospitals, Long-Term Care Facilities, and Others), and Region 2025-2033

 Report
February 2025
150 Pages
Global

From

€2743EUR$2,999USD£2,335GBP

2,452 Results (Page 73 of 123)
- 1
- 71
- 72
- 73
- 74
- 75

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.